Paradoxical results in the study of risk factors of chronic obstructive pulmonary disease (COPD) re-admission

被引:5
|
作者
Garcia-Aymerich, J
Marrades, RM
Monsó, E
Barreiro, E
Farrero, E
Antó, JM
机构
[1] IMIM, Resp & Environm Hlth Res Unit, E-08003 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain
[3] Hosp Germans Trias & Pujol, Dept Pneumol, Barcelona, Spain
[4] Hosp Mar, Dept Pneumol, Barcelona, Spain
[5] Ciudad Sanitaria & Univ Bellvitge, Hosp Llobregat, Dept Pneumol, Lhospitalet De Llobregat, Spain
[6] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
关键词
COPD; confounding by indication; confounding by severity; paradoxical results;
D O I
10.1016/j.rmed.2004.02.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously reported an apparently paradoxical association between medical care related factors and an increased risk of chronic obstructive pulmonary disease (COPD) re-hospitalisation, in a cohort of 346 COPD subjects from Barcelona, Spain. Confounding by severity or by indication is a plausible explanation. We tested the confounding effect of severity-related variables on these paradoxical associations. Forced expiratory volume in one second (FEV1), arterial oxygen pressure (PO2) and previous COPD admissions were associated with: (1) the presence of medical care related factors, and (2) re-admission during follow-up. Risks of readmission associated with most of the medical care related factors were reduced after adjustment for the severity variables. The risk associated with tong-term oxygen therapy use changed from a crude OR of 2.36 (95% CI: 1.79-3.11) to an adjusted OR of 1.38 (0.95-2.00), while that associated with anticholinergics use varied from 3.52 (2.37-5.21) to 2.10 (1.32-3.36)). We concluded that the excess risk of COPD re-admission associated with medical care related factors might be partially due to confounding by indication. Residual confounding may still account for part of the remaining excess risk. True adverse effects of some pharmacological treatments cannot be excluded. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:851 / 857
页数:7
相关论文
共 50 条
  • [31] Risk Factors for 30-Day Re-Admission in Adults with Sickle Cell Disease
    Brodsky, Max A.
    McClain, Brandi L.
    Byrd, Jeannie
    Roberts, Dionna O.
    Melvin, Brittany Danielle
    Rodeghier, Mark
    DeBaun, Michael R.
    Kassim, Adetola A.
    BLOOD, 2014, 124 (21)
  • [32] EPIDEMIOLOGIC STUDY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Oemiati, Ratih
    MEDIA PENELITIAN DAN PENGEMBANGAN KESEHATAN, 2013, 23 (02): : 82 - 88
  • [33] The risk factors for hospital re-admission in medical patients in Singapore
    Chan, Moon Fai
    Wong, Frances K. Y.
    HEALTH & SOCIAL CARE IN THE COMMUNITY, 2014, 22 (05) : 488 - 496
  • [34] The Lifetime Risk Of Developing Chronic Obstructive Pulmonary Disease (COPD)
    Gershon, A. S.
    Warner, L.
    Cascagnette, P.
    Victor, J. C.
    To, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [35] A Causal Model of Chronic Obstructive Pulmonary Disease (COPD) Risk
    Cox, Louis Anthony , Jr.
    RISK ANALYSIS, 2011, 31 (01) : 38 - 62
  • [36] Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease
    Ozyilmaz, E.
    Kokturk, N.
    Teksut, G.
    Tatlicioglu, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (07) : 691 - 697
  • [37] Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
    Molimard, M.
    Blin, P.
    Maleyran, S. Lignot
    Lassalle, R.
    Lamarque, S.
    Bernard, M. A.
    Demeaux, J. L.
    Guillemot, D.
    Housset, B.
    Mayaud, C.
    Peyramond, D.
    Pouchain, D.
    Moore, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 7 - 7
  • [38] Management of chronic obstructive pulmonary disease (COPD) exacerbations: Results of a French cohort study
    Blin, P.
    Lignot, S.
    Lamarque, S.
    Lassalle, R.
    Bernard, M-A
    Guillemot, D.
    Mayaud, C.
    Moore, N.
    Molimard, M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S184 - S185
  • [39] Chronic Obstructive Pulmonary Disease (COPD)
    Lareau, Suzanne C.
    Fahy, Bonnie
    Meek, Paula
    Wang, Angela
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (01)
  • [40] Chronic obstructive pulmonary disease (COPD)
    Feetham, Laura
    van Dorn, Aaron
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 18 - 19